Moderna’s Covid-19 vaccine had been in the news when it was held aloft as among the best vaccines ever. The Company exported the vaccines to poorer countries, but now a report has said that these countries have received very few doses compared to wealthier nations.
According to a Business Insider report, which quoted data from Airfinity, a firm that tracks vaccine shipments, the Company had shipped only about a million vaccine doses to low-income countries. The report added that this is against 8.4 million doses of Pfizer’s vaccine and around 25 million of Johnson & Johnson’s vaccine.
It has also been noted that a handful of middle-income nations had to pay more for the vaccine than the United States. Meanwhile, countries such as Botswana, which had entered into agreements with Moderna, did not receive their doses at all. The report also said that nations like Tunisia could not even connect with Moderna for the vaccine doses they had expected to arrive.
250 Mn vaccinated with Moderna Vaccine, Says Company
The Company had earlier stated that it aimed to help protect as many people as possible worldwide. In a media release, Moderna had more than 250 million people have been vaccinated globally with the Moderna COVID-19 vaccine. That access to vaccines remains a challenge in many parts of the world.
The Company focused on “implementing a comprehensive and always evolving strategy to ensure that low-income countries get access to our vaccine,” it had said in the media release.
Moderna Vaccine Offers Better Protection
It has already been reported that Moderna’s vaccine offers better protection compared to Pfizer’s and Johnson & Johnson’s over time. This is based on data from hospitals in 20 cities, which had shown that the Moderna vaccine was 92 percent effective at preventing hospitalizations after four months.